TY  - JOUR
AU  - Masjuan, J
AU  - Gállego, J
AU  - Aguilera, J M
AU  - Arenillas, J F
AU  - Castellanos, M
AU  - Díaz, F
AU  - Portilla, J C
AU  - Purroy, F
PY  - 2018
DO  - 10.1016/j.nrl.2017.10.013
UR  - http://hdl.handle.net/10668/11993
T2  - Neurologia (Barcelona, Spain)
AB  - There is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence to treatment. The CV polypill may contribute to proper treatment adherence, which is necessary for CV...
LA  - en
KW  - Adherencia terapéutica
KW  - Cerebrovascular disease
KW  - Combinación de dosis fijas
KW  - Enfermedad cerebrovascular
KW  - Fixed-dose combination
KW  - ICTUS
KW  - Medication adherence
KW  - Polypill
KW  - Prevención secundaria
KW  - Secondary prevention
KW  - Stroke
KW  - Aged
KW  - Brain Ischemia
KW  - Cerebrovascular Disorders
KW  - Drug Combinations
KW  - Humans
KW  - Medication Adherence
KW  - Secondary Prevention
KW  - Stroke
TI  - Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease.
T2  - Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular.
TY  - research article
VL  - 36
ER  -